内源性大麻素系统的体内成像：开启人类中枢调节机制的新窗口。 - Suppr

Suppr

超能文献

In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

作者信息

Van Laere Koen

出版信息

Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1719-26. doi: 10.1007/s00259-007-0505-3.

DOI:10.1007/s00259-007-0505-3

PMID:17643242

Abstract

摘要

相似文献

In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1719-26. doi: 10.1007/s00259-007-0505-3.

PET and SPECT in drug evaluation and drug design imaging inflammatory processes, tumors, and the endocannabinoid system.

Curr Pharm Des. 2008;14(31):3295-6. doi: 10.2174/138161208786549407.

In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.

Brain. 2011 Apr;134(Pt 4):1033-40. doi: 10.1093/brain/awq385. Epub 2011 Feb 8.

The endocannabinoid system in the brain: from biology to therapy.

Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):613. doi: 10.2174/156800705774933078.

Has PET become an important clinical tool in paediatric imaging?

Eur J Nucl Med Mol Imaging. 2004 May;31(5):615-21. doi: 10.1007/s00259-004-1470-8. Epub 2004 Feb 5.

Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Physiol Behav. 2008 Mar 18;93(4-5):671-86. doi: 10.1016/j.physbeh.2007.11.012. Epub 2007 Nov 21.

Endocannabinoid control of food intake and energy balance.

Nat Neurosci. 2005 May;8(5):585-9. doi: 10.1038/nn1457.

Molecular imaging update: advances in MI of the brain.

J Nucl Med. 2007 May;48(5):24N, 29N.

Multiple sclerosis may disrupt endocannabinoid brain protection mechanism.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6087-8. doi: 10.1073/pnas.0601847103. Epub 2006 Apr 10.

Endocannabinoid mechanisms of pain modulation.

AAPS J. 2006 Nov 17;8(4):E693-708. doi: 10.1208/aapsj080479.

引用本文的文献

Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain.

J Neurosci Res. 2023 Mar;101(3):327-337. doi: 10.1002/jnr.25149. Epub 2022 Nov 28.

Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects.

Front Behav Neurosci. 2020 Dec 11;14:596509. doi: 10.3389/fnbeh.2020.596509. eCollection 2020.

Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.

CNS Drugs. 2015 Apr;29(4):313-30. doi: 10.1007/s40263-015-0237-z.

The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1164-73. doi: 10.1007/s00259-010-1383-7. Epub 2010 Feb 25.

Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands.

J Nucl Med. 2010 Jan;51(1):112-20. doi: 10.2967/jnumed.109.067074. Epub 2009 Dec 15.

Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.

Bioorg Med Chem Lett. 2009 Nov 1;19(21):6209-12. doi: 10.1016/j.bmcl.2009.08.092. Epub 2009 Sep 3.

本文引用的文献

Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.

J Med Chem. 2007 Jul 26;50(15):3427-30. doi: 10.1021/jm070131b. Epub 2007 Jul 3.

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5. doi: 10.1073/pnas.0703472104. Epub 2007 May 29.

Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.

J Neurochem. 2007 Aug;102(4):1105-14. doi: 10.1111/j.1471-4159.2007.04642.x. Epub 2007 May 4.

[The endocannabinoid system as a novel target for the treatment of liver fibrosis].

Pathol Biol (Paris). 2008 Feb;56(1):36-8. doi: 10.1016/j.patbio.2007.01.001. Epub 2007 Apr 6.

Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration.

J Neurosci. 2007 Apr 4;27(14):3695-702. doi: 10.1523/JNEUROSCI.4403-06.2007.

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.

Nat Med. 2007 Apr;13(4):492-7. doi: 10.1038/nm1561. Epub 2007 Apr 1.

The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.

Neuropsychopharmacology. 2008 Jan;33(2):259-69. doi: 10.1038/sj.npp.1301402. Epub 2007 Mar 28.

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

J Neurosci. 2007 Feb 28;27(9):2396-402. doi: 10.1523/JNEUROSCI.4814-06.2007.

From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches.

Mult Scler. 2007 Jan;13(1):133-4. doi: 10.1177/1352458506071303.

The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.

Prog Neurobiol. 2007 Apr;81(5-6):349-79. doi: 10.1016/j.pneurobio.2006.11.006. Epub 2007 Feb 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验